NBOCA work on bowel cancer in patients with inflammatory bowel disease published
NBOCA has published a paper on outcomes in patients with colorectal cancer and inflammatory bowel disease.
NBOCA has published a paper on outcomes in patients with colorectal cancer and inflammatory bowel disease.
The final date for uploading data for the NBOCA 2022 report will be 10th June.
The majority of the results in this report are for patients diagnosed 1 April 2019 to 31 March 2020. A separate section on the impact of COVID-19 covers patients diagnosed 1 March 2020 to 31 March 2021.
New short report aiming to improve the accuracy and robustness of the methodology used to measure rectal surgery volume, as well as exploring patient, institution, and surgeon-level characteristics according to rectal surgery volumes.
With Covid-19 continuing to impact services it’s difficult to be certain what the situation will be next year. We will continue to respond to national guidance from our commissioners and we will keep you informed of any changes.
NBOCA has published a paper on the impact of completion of adjuvant chemotherapy for stage III colon cancer on 3-year cancer-specific mortality.
The NBOCA QI Plan will be launching on 5th October 2021.
NBOCA have now published two papers evaluating the impacts of COVID-19 on colorectal cancer care.
New short report published looking at colorectal cancer in those diagnosed under 50 years old, with particular emphasis on characteristics and outcomes of those diagnosed with metastatic colon cancer.
Copyright © 2022 National Bowel Cancer Audit | Lovingly Crafted by Mixd